Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
Becton Dickinson and Co'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Becton Dickinson and Co'in toplam varlıkları $0 olup, net 損失 $0'dir.
BDX'ün temel finansal oranları nelerdir?
Becton Dickinson and Co'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
Becton Dickinson and Co'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Becton Dickinson and Co の最大収益セグメントは Medication Delivery Solutions で、最新の利益発表における収益は 4,575,000,000 です。地域別に見ると、United States が Becton Dickinson and Co の主要市場であり、収益は 12,790,000,000 です。
Becton Dickinson and Co kârlı mı?
いいえ, son mali tablolara göre Becton Dickinson and Co'in net 損失 $0'dir.
Becton Dickinson and Co'in herhangi bir yükümlülüğü var mı?
いいえ, Becton Dickinson and Co'in yükümlülüğü 0'dir.
Becton Dickinson and Co'in tedavüldeki hisse sayısı kaçtır?
Becton Dickinson and Co'in toplam tedavüldeki hisse sayısı 0'dir.